5-HT receptors
5-HT receptors
The serotonin receptors, also
known as 5-hydroxytryptamine receptors or 5-HT receptors, are a
group of G protein-coupled receptors (GPCRs) and ligand-gated ion channels
(LGICs) found in the central and peripheral nervous systems. They mediate both
excitatory and inhibitory neurotransmission. The serotonin receptors are
activated by the neurotransmitter serotonin, which acts as their natural
ligand. The 5-HT1B receptor as an example of a metabotropic
serotonin receptor.
The serotonin receptors modulate the
release of many neurotransmitters, including glutamate, GABA, dopamine,
epinephrine / norepinephrine, and acetylcholine, as well as many hormones,
including oxytocin, prolactin, vasopressin, cortisol, corticotropin, and
substance P, among others. The serotonin receptors influence various biological
and neurological processes such as aggression, anxiety, appetite, cognition,
learning, memory, mood, nausea, sleep, and thermoregulation. The serotonin
receptors are the target of a variety of pharmaceutical drugs, including many
antidepressants, antipsychotics, anorectics, antiemetics, gastroprokinetic
agents, antimigraine agents, hallucinogens, and entactogens.
Serotonin receptors are found in
almost all animals and are even known to regulate longevity and behavioral
aging in the primitive nematode, Caenorhabditis elegans.
Classification
With
the exception of the 5-HT3 receptor, a ligand-gated ion channel, all
other serotonin receptors are G protein-coupled receptors that activate an
intracellular second messenger cascade to produce an excitatory or inhibitory
response. In 2014 a novel 5-HT receptor was described that was isolated from
the small white butterfly, Pieris rapae, and named pr5-HT8. It
shares relatively low similarity to the known 5-HT receptor classes and does
not occur in mammals.
Families
Family
|
Type
|
Mechanism
|
Potential
|
5-HT1
|
Gi/Go-protein coupled.
|
Decreasing cellular levels of cAMP.
|
Inhibitory
|
5-HT2
|
Gq/G11-protein coupled.
|
Increasing cellular levels of IP3
and DAG.
|
Excitatory
|
5-HT3
|
Ligand-gated Na+ and K+
cation channel.
|
Depolarizing plasma membrane.
|
Excitatory
|
5-HT4
|
Gs-protein coupled.
|
Increasing cellular levels of cAMP.
|
Excitatory
|
5-HT5
|
Gi/Go-protein coupled.
|
Decreasing cellular levels of cAMP.
|
Inhibitory
|
5-HT6
|
Gs-protein coupled.
|
Increasing cellular levels of cAMP.
|
Excitatory
|
5-HT7
|
Gs-protein coupled.
|
Increasing cellular levels of cAMP.
|
Excitatory
|
Subtypes
The 7 general serotonin receptor classes
include a total of 14 known serotonin receptors.[8] The
specific types have been characterized as follows:
Overview
of Serotonin Receptors
Receptor
(first cloned) |
Gene(s)
|
Distribution
|
Function
|
Agonists
|
Antagonists
|
Uses of drugs that act on this
receptor
|
5-HT1A
(1987) |
·
HTR1A
|
·
Blood Vessels
·
CNS
|
·
Addiction
·
Aggression
·
Anxiety
·
Appetite
·
Autoreceptor
·
Blood Pressure
·
Cardiovascular Function
·
Emesis
·
Heart Rate
·
Impulsivity
·
Memory
·
Mood
·
Nausea
·
Nociception
·
Penile Erection
·
Pupil Dilation
·
Respiration
·
Sexual Behavior
·
Sleep
·
Sociability
·
Thermoregulation
·
Vasoconstriction
|
Selective (for 5-HT1A over other 5-HT
receptors)
·
F-15,599
(research compound, highly potent and selective for 5-HT1A)
·
Flesinoxan
(potent, EC50 = 24 nM)
·
Gepirone (partial
agonist, Ki = 70 nM)
·
Haloperidol
·
Ipsapirone
(partial agonist, Ki = 12.1 nM)
·
Quetiapine
·
Trazodone (SARI,
selective in the sense that on all other 5-HT receptors it acts as either an
antagonist or has no action. Kd = 78nM)
·
Yohimbine
(unselective partial agonist)
·
Tandospirone
(potent and selective partial agonist)
Nonselective
·
5-CT
(potent - Ki = 250±50 pM)
·
8-OH-DPAT
(potent)
·
Aripiprazole
(atypical antipsychotic)
·
Asenapine
(atypical antipsychotic)
·
Buspirone
(partial agonist)
·
Vortioxetine
(high-efficacy partial agonist)
·
Ziprasidone
(Partial agonist, Ki = 3.4 nM)
|
·
BMY 7378
·
Cyanopindolol
·
Iodocyanopindolol
·
Lecozotan
·
Methiothepin
·
Methysergide
·
NAN-190
·
Nebivolol
·
Nefazodone
·
WAY-100,135
·
WAY-100,635
·
Mefway
|
·
Analgesics
(agonists)
·
Antidepressants (post-synaptic receptor agonists and pre-synaptic autoreceptor
antagonists serve as antidepressants)
·
Anxiolytics
(antagonist)
|
5-HT1B
(1992) |
·
HTR1B
|
·
Blood Vessels
·
CNS
|
·
Addiction
·
Aggression
·
Anxiety
·
Autoreceptor
·
Learning
·
Locomotion
·
Memory
·
Mood
·
Penile Erection
·
Sexual Behavior
·
Vasoconstriction
|
·
5-CT
·
CGS-12066A
·
CP-93,129
·
CP-94,253
·
Dihydroergotamine
·
Eltoprazine
·
Ergotamine
·
Methysergide
·
RU 24969
·
TFMPP
·
Triptans (antimigraine)
o
Zolmitriptan
o
Eletriptan
o
Sumatriptan
·
Vortioxetine
(partial agonist, Ki = 33 nM)
|
·
Alprenolol
·
AR-A000002
·
Asenapine
·
Cyanopindolol
·
GR-127,935
·
Iodocyanopindolol
·
Isamoltane
·
Metergoline
·
Methiothepin
·
Oxprenolol
·
Pindolol
·
Propranolol
·
SB-216,641
·
Yohimbine
|
·
Migraines (e.g. triptans)
|
5-HT1D
(1991) |
·
HTR1D
|
·
Blood Vessels
·
CNS
|
·
Anxiety
·
Autoreceptor
·
Locomotion
·
Vasoconstriction
|
·
5-CT
·
CP-135,807
·
Dihydroergotamine
·
Ergotamine
·
Methysergide
·
Triptans (antimigraine)
o
Almotriptan
o
Eletriptan
o
Frovatriptan
o
Naratriptan
o
Rizatriptan
o
Sumatriptan
o
Zolmitriptan
·
Yohimbine
|
·
BRL-15572
·
GR-127,935
·
Ketanserin
·
Metergoline
·
Methiothepin
·
Rauwolscine
·
Ritanserin
·
Vortioxetine (Ki
= 54 nM)
·
Ziprasidone
|
·
Migraines (e.g. triptans)
|
5-HT1E
(1992) |
·
HTR1E
|
·
Blood Vessels
·
CNS
|
·
BRL-54443
|
·
None known
|
||
5-HT1F
(1993) |
·
HTR1F
|
·
CNS
|
·
Migraine
|
·
BRL-54443
·
Lasmiditan
·
LY-334,370
·
Naratriptan
|
·
None known
|
|
5-HT2A
(1988) |
·
HTR2A
|
·
Blood Vessels
·
CNS
·
GI Tract
·
Platelets
·
PNS
·
Smooth Muscle
|
·
Addiction (potentially modulating)
·
Anxiety
·
Appetite
·
Cognition
·
Imagination
·
Learning
·
Memory
·
Mood
·
Perception
·
Sexual Behavior
·
Sleep
·
Thermoregulation
·
Vasoconstriction
|
·
25I-NBOMe (Full
agonist)
·
2C-B
·
5-MeO-DMT
·
BZP
·
Bufotenin
·
DMT
·
DOM
·
Ergonovine
·
Lisuride
·
LSD
·
Mescaline
·
Myristicin
·
PNU-22394
(Partial agonist)
·
Psilocin
·
Psilocybin
·
TFMPP
(partial agonist or antagonist)
|
·
Atypical antipsychotics
o
Clozapine
o
Olanzapine
o
Quetiapine
o
Risperidone
o
Ziprasidone
·
Aripiprazole
·
Asenapine
·
Amitriptyline
·
Clomipramine
·
Cyproheptadine
·
Eplivanserin
·
Etoperidone
·
Haloperidol
·
Hydroxyzine
·
Iloperidone
·
Ketanserin (antihypertensive)
·
Methysergide
·
Mianserin
·
Mirtazapine
·
Nefazodone
·
Pimavanserin
·
Pizotifen
·
Ritanserin
·
Trazodone
·
Yohimbine
|
·
Atypical antipsychotics (antagonist)
·
Psychedelics
(partial agonists)
·
NaSSAs
(antidepressants and anxiolytics; they serve as antagonists at this site)
·
Treating serotonin syndrome (antagonists; e.g. cyproheptadine)
·
Sleeping aid (antagonists; e.g. trazodone)
|
5-HT2B
(1992) |
·
HTR2B
|
·
Blood Vessels
·
CNS
·
GI Tract
·
Platelets
·
PNS
·
Smooth Muscle
|
·
Anxiety
·
Appetite
·
Cardiovascular Function
·
GI Motility
·
Sleep
·
Vasoconstriction
|
·
BW-723C86
·
Fenfluramine
·
MDMA
·
Norfenfluramine
·
PNU-22394
(Partial agonist)
·
Ro60-0175
|
·
Agomelatine
·
Asenapine
·
BZP
·
Ketanserin
·
Methysergide
·
Ritanserin
·
RS-127,445
·
Tegaserod
·
Yohimbine
|
·
Migraines
(antagonists)
|
5-HT2C
(1988) |
·
HTR2C
|
·
Blood Vessels
·
CNS
·
GI Tract
·
Platelets
·
PNS
·
Smooth Muscle
|
·
Addiction. (potentially modulating)
·
Anxiety
·
Appetite
·
GI Motility
·
Heteroreceptor for norepinephrine and dopamine
·
Locomotion
·
Mood
·
Penile Erection
·
Sexual Behavior
·
Sleep
·
Thermoregulation
·
Vasoconstriction
|
·
A-372,159
·
AL-38022A
·
Aripiprazole
·
Ergonovine
·
Lorcaserin
·
PNU-22394 (Full
agonist)
·
Ro60-0175
·
TFMPP
·
Trazodone (hypnotic)
·
YM-348
|
·
Agomelatine (antidepressant)
·
Amitriptyline
·
Asenapine
·
Clomipramine
·
Clozapine (antipsychotic)
·
Cyproheptadine
·
Dimebolin
·
Eltoprazine
·
Etoperidone
·
Fluoxetine
·
Haloperidol
·
Iloperidone
·
Ketanserin (antihypertensive)
·
Lisuride
·
Methysergide
·
Mianserin
·
Mirtazapine
·
Nefazodone
·
Olanzapine
·
Paroxetine
·
Quetiapine
·
Risperidone
·
Ritanserin
·
Tramadol
·
Trazodone
·
Ziprasidone
|
·
Antidepressant (e.g. agomelatine, fluoxetine, mirtazapine)
·
Orexigenic (e.g.
mirtazapine, clozapine and olanzapine; antagonists)
·
Anorectic
(Lorcaserin)
·
Antipsychotic (Vabicaserin; agonists)
|
5-HT3
(1993) |
·
HTR3A
·
HTR3B
·
HTR3C
·
HTR3D
·
HTR3E
|
·
CNS
·
GI Tract
·
PNS
|
·
Addiction
·
Anxiety
·
Emesis
·
GI Motility
·
Learning
·
Memory
·
Nausea
|
·
2-Methyl-5-HT
·
BZP
·
Quipazine
·
RS-56812
|
·
Alosetron
·
Several antiemetics
o
Dolasetron
o
Ondansetron
o
Granisetron
o
Tropisetron
·
Clozapine
·
Memantine
·
Metoclopramide
·
Mianserin
·
Mirtazapine
·
Olanzapine
·
Quetiapine
·
Vortioxetine (Ki
= 3.7 nM)
|
·
Antiemetic
|
5-HT4
(1995) |
·
HTR4
|
·
CNS
·
GI Tract
·
PNS
|
·
Anxiety
·
Appetite
·
GI Motility
·
Learning
·
Memory
·
Mood
·
Respiration
|
·
5-MT
·
BIMU-8
·
Cinitapride
·
Cisapride (gastroprokinetic)
·
Dazopride
·
Metoclopramide
·
Mosapride
·
Prucalopride
·
RS-67333
·
Renzapride
·
Tegaserod
·
Zacopride
|
·
L-Lysine
·
Piboserod
|
·
Gastroprokinetics (e.g. Tegaserod)
|
5-HT5A
(1994) |
·
HTR5A
|
·
CNS
|
·
Autoreceptor
·
Locomotion[81]
·
Sleep
|
·
5-CT
·
Ergotamine
·
Valerenic Acid (partial agonist)
|
·
Asenapine
·
Dimebolin
·
Methiothepin
·
Ritanserin
·
SB-699,551
·
SB-699,551-A
|
·
None thus far
|
5-HT5B
(1993) |
·
HTR5BP
|
·
functions in rodents,
pseudogene in humans |
·
None thus far
|
|||
5-HT6
(1993) |
·
HTR6
|
·
CNS
|
·
Anxiety
·
Cognition
·
Learning
·
Memory
·
Mood
|
·
EMD-386,088
·
EMDT
|
·
Amitriptyline
·
Aripiprazole
·
Asenapine
·
Clomipramine
·
Clozapine
·
Dimebolin
·
EGIS-12233
·
Haloperidol
·
Iloperidone
·
MS-245
·
Olanzapine
·
Ro04-6790
·
SB-258,585
·
SB-271,046
·
SB-357,134
·
SB-399,885
|
·
Antidepressant (antagonists and agonists)
·
Anxiolytic
(antagonists and agonist)
·
Nootropic
(antagonists)
·
Anorectic
(antagonists)
|
5-HT7
(1993) |
·
HTR7
|
·
Blood Vessels
·
CNS
·
GI Tract
|
·
Anxiety
·
Autoreceptor
·
Memory
·
Mood
·
Respiration
·
Sleep
·
Thermoregulation
·
Vasoconstriction
|
·
5-CT
·
8-OH-DPAT
·
Aripiprazole (weak partial
agonist)
·
AS-19
·
E-55888
·
RA-7
|
·
Amitriptyline
·
Asenapine
·
Clomipramine
·
Clozapine
·
EGIS-12233
·
Haloperidol
·
Iloperidone
·
Imipramine
·
Ketanserin
·
Mirtazapine
·
Olanzapine
·
Ritanserin
·
Risperidone
·
SB-269,970
·
Vortioxetine (Ki
= 19 nM)
|
·
Antidepressant (antagonists)
·
Anxiolytics
(antagonists)
·
Nootropic
(antagonists)
|
Note that there is no 5-HT1C receptor
since, after the receptor was cloned and further characterized, it was found to
have more in common with the 5-HT2 family of receptors and was
redesignated as the 5-HT2C receptor.
Very nonselective agonists of 5-HT receptor
subtypes include ergotamine (an antimigraine), which activates
5-HT1A, 5-HT1D, 5-HT1B, D2 and norepinephrine receptors. LSD (a psychedelic)
is a 5-HT1A, 5-HT2A, 5-HT2C, 5-HT5A, 5-HT5, 5-HT6 agonist.
5-HT4 receptor
[5-hydroxytryptamine (serotonin)
receptor 4, G protein-coupled]
5-Hydroxytryptamine
receptor 4 is a protein that in humans is encoded by the HTR4 gene.
This gene is a member of the family of human serotonin
receptors, which are G protein-coupled receptors that stimulate cAMP production
in response to serotonin (5-hydroxytryptamine). The gene product is a
glycosylated transmembrane protein that functions in both the peripheral and
central nervous system to modulate the release of various neurotransmitters.
Multiple transcript variants encoding proteins with distinct C-terminal
sequences have been described, but the full-length nature of some transcript
variants has not been determined.
Location
The
receptor is located in the alimentary tract, urinary bladder, heart and adrenal
gland as well as the central nervous system (CNS). In the CNS the receptor
appears in the putamen, caudate nucleus, nucleus accumbens, globus pallidus,
and substantia nigra, and to a lesser extent in the neocortex, raphe, pontine
nuclei, and some areas of the thalamus. It has not been found in the
cerebellum.
Isoforms
Internalization is isoform-specific.
Ligands
Several
drugs that act as 5-HT4 selective agonists have recently been
introduced into use in both scientific research and clinical medicine. Some
drugs that act as 5-HT4 agonists are also active as 5-HT3
antagonists, such as mosapride, metoclopramide, renzapride, and zacopride, and
so these compounds cannot be considered highly selective. Research in this area
is ongoing.
SB-207,145
radiolabeled with carbon-11 is used as a radioligand for 5-HT4 in
positron emission tomography pig and human studies.
Agonists
- BIMU-8
- Cisapride
- CJ-033,466
- partial agonist
- ML-10302
- Mosapride
- Prucalopride
- Renzapride
- RS-67506
- RS-67333
- partial agonist
- SL65.0155
- partial agonist
- Tegaserod
- Zacopride
- Metoclopramide
- Sulpiride
Antagonists
- Piboserod
- GR-113,808
(1-methyl-1H-indole-3-carboxylic acid, [1-[2-[(methylsulfonyl) amino] ethyl]
-4-piperidinyl]methyl ester)
- GR-125,487
- RS-39604
(1-[4-Amino-5-chloro-2-(3,5-dimethoxyphenyl)methyloxy]-3-[1-[2-methyl sulphonylamino]piperidin-4-yl]propan-1-one)
- SB-203,186
- SB-204,070
- ([Methoxy-11C]1-butylpiperidin-4-yl)methyl
4-amino-3-methoxybenzoate
- Chamomile
(ethanol extract)
Comments
Post a Comment